The Influence of GPX1 Pro198Leu, CAT C262T and MnSOD Ala16Val Gene Polymorphisms on Susceptibility for Non-Hodgkin Lymphoma and Overall Survival Rate at Five Years from Diagnosis

1. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012; 380(9844):848-857.10.1016/S0140-6736(12)60605-9Search in Google Scholar

2. Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017; 390(10091):298-310.10.1016/S0140-6736(16)32407-2Search in Google Scholar

3. Perry AM, Diebold J, Nathwani BN et al. Non-Hodgkin lymphoma in the Far East: review of 730 cases from the International non-Hodgkin Lymphoma Classification Project. Ann Hematol. 2016; 95(2):245-251.10.1007/s00277-015-2543-426537613Search in Google Scholar

4. Perry AM, Diebold J, Nathwani BN et al. Non-Hodgkin Lymphoma In The Developing World: Review Of 4539 Cases From The International Non-Hodgkin Lymphoma Classification Project. Haematologica. 2016; 101(10):1244-1250.10.3324/haematol.2016.148809504665427354024Search in Google Scholar

5. Bogliș A, Radu CG, Tripon F et al. XRCC1 Arg194Trp and Arg399Gln Polymorphisms and Risk of Non-Hodgkin Lymphoma in a Romanian Population. Rev Med Chir Soc Med Nat Iasi. 2016; 120(3):644-650.Search in Google Scholar

6. Bogliș A, Crauciuc AG, Tripon F et al. No association between GSTT1, GSTM1 and GSTP1 gene polymorphism and risk of non-Hodgkin lymphoma in a population from Romania. International Journal of Innovation and Applied Studies. 2017; 19(1):1-8.Search in Google Scholar

7. Dotlic S, Perry AM, Petrusevska G et al. Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin classification project. Br J Haematol. 2015; 171(3):366-372.10.1111/bjh.1358626213902Search in Google Scholar

8. Moriya K, Tamura H, Nakamura K, Hosone M, Inokuchi K. A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment. Leuk Res Rep. 2017; 7:2-5.10.1016/j.lrr.2016.12.001Search in Google Scholar

9. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010; 49 (11):1603-1616.10.1016/j.freeradbiomed.2010.09.006299047520840865Search in Google Scholar

10. Lightfoot TJ, Skibola CF, Smith AG et al. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin’s lymphoma. Haematologica. 2006; 91(9):1222-1227.Search in Google Scholar

11. Baecklund E, Iliadou A, Askling J et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006; 54(3):692-701.10.1002/art.2167516508929Search in Google Scholar

12. Callan MF. Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr Opin Rheumatol. 2004; 16(4):399-405.10.1097/01.bor.0000126149.96627.8215201603Search in Google Scholar

13. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjogren’s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev. 2005; 4(1):8-15.10.1016/j.autrev.2004.04.00415652773Search in Google Scholar

14. Laurent A, Nicco C, Chéreau C et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 2005; 65(3):948–956.10.1158/0008-5472.948.65.3Search in Google Scholar

15. SNPedia database. Catalase gene. Avaiable at https://www.snpedia.com/index.php?title=Special%3ASearch&search=catalase&fulltext=1. Last time accessed on 27 January, 2019.Search in Google Scholar

16. NCBI. Catalase gene. Available from http://ncbi.nlm.nih.gov/gene847. Last time accessed on 27 January, 2019.Search in Google Scholar

17. Wang CD, Sun Y, Chen N et al. The Role of Catalase C262T Gene Polymorphism in the Susceptibility and Survival of Cancers. Sci Rep. 2016; 6:26973.10.1038/srep26973488092227225983Search in Google Scholar

18. Bănescu C, Iancu M, Trifa AP et al. From Six Gene Polymorphisms of the Antioxidant System, Only GPX Pro198Leu and GSTP1 Ile105Val Modulate the Risk of Acute Myeloid Leukemia. Oxid Med Cell Longev. 2016; 6:1-10.10.1155/2016/2536705470732526823947Search in Google Scholar

19. Farawela H, Khorshied M, Shaheen I et al. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin’s lymphoma risk in Egypt. Infect Genet Evol. 2012; 12(6):1189–1194.10.1016/j.meegid.2012.04.00722522002Search in Google Scholar

20. Ekoue DN, Bera S, Ansong E et al. Allelic variations in MnSOD and GPx-1 affect metabolism, mitochondrial membrane potential and expression of signaling proteins. Proceedings of the AACR 107th Annual Meeting 2016; April 16-20; New Orleans, LA: Cancer Res; 2016; 76(14).10.1158/1538-7445.AM2016-225Search in Google Scholar

21. Wang SS, David S, Cerhan JR et al. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis. 2006; 27(9):1828-1834.10.1093/carcin/bgl01316543247Search in Google Scholar

22. Paz-y-Miño C, Muñoz MJ, López-Cortés A et al. Frequency of polymorphisms Pro198Leu in GPX-1 gene and Ile58Thr in MnSOD gene in the altitude Ecuadorian population with bladder cancer. Oncol Res. 2010; 18(8):395–400.10.3727/096504010X12644422320780Search in Google Scholar

23. Bănescu C, Trifa AP, Voidăzan S et al. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study. Oxid Med Cell Longev. 2014; 2014: 875861.10.1155/2014/875861424313525436036Search in Google Scholar

24. Negovan A, Iancu M, Tripon F, Crauciuc A, Mocan S, Bănescu C. The CAT-262 C>T, MnSOD Ala16Val, GPX1 Pro198Leu Polymorphisms Related to Oxidative Stress and the Presence of Gastric Lesions. J Gastrointestin Liver Dis. 2018; 27(4):371-378.10.15403/jgld.2014.1121.274.cat30574618Search in Google Scholar

25. Nogai H, Dörken B, Lenz G. Pathogenesis of Non-Hodgkin’s Lymphoma. J Clin Oncol. 2011; 29(14):1803-1811.10.1200/JCO.2010.33.325221483013Search in Google Scholar

26. Al-Alem U, Gann PH, Dahl J et al. Associations between functional polymorphisms in antioxidant defense genes and urinary oxidative stress biomarkers in healthy, premenopausal women. Genes Nutr. 2012; 7(2):191–195.10.1007/s12263-011-0257-3331674622068340Search in Google Scholar

27. Yuzhalin AE, Kutikhin AG. Inherited variations in the SOD and GPX gene families and cancer risk. Free Radic Res. 2012; 46(5):581–599.10.3109/10715762.2012.65851522257147Search in Google Scholar

28. Ahn J, Nowell S, McCann SE et al. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev. 2006; 15(6):1217-1222.10.1158/1055-9965.EPI-06-010416775184Search in Google Scholar

29. Skibola CF, Curry JD, Nieters A. Genetic Susceptibility to Lymphoma. Haematologica. 2007; 92(7):960-969.10.3324/haematol.11011281916517606447Search in Google Scholar

30. Kang SW. Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis. Int J Clin Exp Med. 2015; 8(9):14647-14655.Search in Google Scholar

31. Bewick M, Coutie W, Tudhope GR. Superoxide dismutase, glutathione peroxidase and catalase in the red cells of patients with malignant lymphoma. Br J Haematol. 1987; 65(3):347–350.10.1111/j.1365-2141.1987.tb06866.x3567087Search in Google Scholar

32. Van Remmen H, Ikeno Y, Hamilton M et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics. 2003; 16(1):29-37.10.1152/physiolgenomics.00122.200314679299Search in Google Scholar